| Bioactivity | MAT2A-IN-6 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally elevated in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-6 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-6 has the potential for the potential for the research of cancer diseases (extracted from patent WO2021254529A1, compound 18)[1]. |
| Name | MAT2A-IN-6 |
| CAS | 2756458-72-5 |
| Formula | C18H13ClF3N3O3 |
| Molar Mass | 411.76 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li Zhen, et al. Bicyclic compounds. Patent WO2021254529A1. |
MAT2A-IN-6
CAS: 2756458-72-5 F: C18H13ClF3N3O3 W: 411.76
MAT2A-IN-6 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally elevated in several types of tumo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.